Ardelyx Inc at HC Wainwright Kidney Virtual Conference Transcript
Hello, and welcome again to the Second Annual H.C. Wainwright Kidney Conference. I'm very pleased to have with us our next presenting company, Ardelyx and representing the company is President and CEO, Mike Raab.
Mike, thank you so much for joining us.
Of course, and good afternoon, everyone. Thank you, H.C. Wainwright for inviting us to this year's Kidney Conference, and really glad to be here and thank you for putting us on. I think it's a critical focus area that we need to as a society and our business be focused more on what's happening with kidney disease.
And ultimately, patients on dialysis, obviously be making forward-looking statements. So if you need any more information on that, you can see in our 10-Q or at the Ardelyx website.
Now, while most of the time I'll be spending today is going to be focused on XPHOZAH and depending we hope approval on October 17, I do want to spend a little bit of time on IBSRELA. It was approved in and we launched last year in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |